Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update
In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice. Based on extensive scientific evidence, CA125 combined with H...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Termedia Publishing House
2022-01-01
|
| Rangatū: | Menopause Review |
| Ngā marau: | |
| Urunga tuihono: | https://www.termedia.pl/Current-clinical-application-of-serum-biomarkers-to-detect-and-monitor-ovarian-cancer-update,4,46144,1,1.html |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|